<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-04833474</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-17T01:21:05+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">What would make the patients prefer a medical teleconsultation in a community pharmacy?</title>
            <author role="aut">
              <persName>
                <forename type="first">Hugo</forename>
                <surname>Girard</surname>
              </persName>
              <email type="md5">7f0c843adcaf0bde19fd787ce1b03c4b</email>
              <email type="domain">etu.univ-grenoble-alpes.fr</email>
              <idno type="idhal" notation="numeric">1180990</idno>
              <idno type="halauthorid" notation="string">2506561-1180990</idno>
              <affiliation ref="#struct-1043157"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jean-Didier</forename>
                <surname>Bardet</surname>
              </persName>
              <email type="md5">cdb3a8583ff4a658317022c27c028f0e</email>
              <email type="domain">univ-grenoble-alpes.fr</email>
              <idno type="idhal" notation="numeric">785870</idno>
              <idno type="halauthorid" notation="string">1302755-785870</idno>
              <idno type="IDREF">https://www.idref.fr/13797020X</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-3254-9474</idno>
              <idno type="ISNI">http://isni.org/isni/0000000357930949</idno>
              <idno type="VIAF">https://viaf.org/viaf/201206108</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/ABI-1253-2020</idno>
              <affiliation ref="#struct-1043060"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Jean-Didier</forename>
                <surname>Bardet</surname>
              </persName>
              <email type="md5">cdb3a8583ff4a658317022c27c028f0e</email>
              <email type="domain">univ-grenoble-alpes.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2024-12-12 12:52:24</date>
              <date type="whenModified">2025-09-27 18:38:41</date>
              <date type="whenReleased">2024-12-12 12:52:24</date>
              <date type="whenProduced">2022-09-18</date>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="202187">
                <persName>
                  <forename>Jean-Didier</forename>
                  <surname>Bardet</surname>
                </persName>
                <email type="md5">cdb3a8583ff4a658317022c27c028f0e</email>
                <email type="domain">univ-grenoble-alpes.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-04833474</idno>
            <idno type="halUri">https://hal.science/hal-04833474</idno>
            <idno type="halBibtex">girard:hal-04833474</idno>
            <idno type="halRefHtml">&lt;i&gt;80th FIP World Congress of Pharmacy and Pharmaceutical Sciences&lt;/i&gt;, Sep 2022, Sevilla (Spain), Spain. Pharmacy education, 23 (3), 2023</idno>
            <idno type="halRef">80th FIP World Congress of Pharmacy and Pharmaceutical Sciences, Sep 2022, Sevilla (Spain), Spain. Pharmacy education, 23 (3), 2023</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UGA">HAL Grenoble Alpes</idno>
            <idno type="stamp" n="IMAG">IMAG</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="INPG">Institut polytechnique de Grenoble</idno>
            <idno type="stamp" n="TIMC-IMAG">TIMC</idno>
            <idno type="stamp" n="TIMC-IMAG-THEMAS" corresp="TIMC-IMAG">ThEMAS : Techniques pour l'Evaluation et la Modélisation des Actions de Santé</idno>
            <idno type="stamp" n="UNIV-LYON">Université de Lyon</idno>
            <idno type="stamp" n="UGA-EPE">Université Grenoble Alpes [2020-*]</idno>
            <idno type="stamp" n="TEST-UGA">TEST-UGA</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="invited" n="0">No</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
            <note type="proceedings" n="0">No</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">What would make the patients prefer a medical teleconsultation in a community pharmacy?</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Hugo</forename>
                    <surname>Girard</surname>
                  </persName>
                  <email type="md5">7f0c843adcaf0bde19fd787ce1b03c4b</email>
                  <email type="domain">etu.univ-grenoble-alpes.fr</email>
                  <idno type="idhal" notation="numeric">1180990</idno>
                  <idno type="halauthorid" notation="string">2506561-1180990</idno>
                  <affiliation ref="#struct-1043157"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jean-Didier</forename>
                    <surname>Bardet</surname>
                  </persName>
                  <email type="md5">cdb3a8583ff4a658317022c27c028f0e</email>
                  <email type="domain">univ-grenoble-alpes.fr</email>
                  <idno type="idhal" notation="numeric">785870</idno>
                  <idno type="halauthorid" notation="string">1302755-785870</idno>
                  <idno type="IDREF">https://www.idref.fr/13797020X</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-3254-9474</idno>
                  <idno type="ISNI">http://isni.org/isni/0000000357930949</idno>
                  <idno type="VIAF">https://viaf.org/viaf/201206108</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/ABI-1253-2020</idno>
                  <affiliation ref="#struct-1043060"/>
                </author>
              </analytic>
              <monogr>
                <meeting>
                  <title>80th FIP World Congress of Pharmacy and Pharmaceutical Sciences</title>
                  <date type="start">2022-09-18</date>
                  <date type="end">2022-09-22</date>
                  <settlement>Sevilla (Spain)</settlement>
                  <country key="ES">Spain</country>
                </meeting>
                <respStmt>
                  <resp>conferenceOrganizer</resp>
                  <name>International Pharmaceutical Federation</name>
                </respStmt>
                <imprint>
                  <biblScope unit="volume">23</biblScope>
                  <biblScope unit="issue">3</biblScope>
                  <date type="datePub">2023</date>
                </imprint>
              </monogr>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="halDomain" n="sdv.sp">Life Sciences [q-bio]/Pharmaceutical sciences</classCode>
              <classCode scheme="halTypology" n="POSTER">Poster communications</classCode>
              <classCode scheme="halOldTypology" n="POSTER">Poster communications</classCode>
              <classCode scheme="halTreeTypology" n="POSTER">Poster communications</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>The medical teleconsultation (MT) has been authorized in French community pharmacies, which have a terminal within a confidentiality area, since 2018. The patient is in contact with a doctor from the service provider. The community pharmacist can assist the patient as needed during the consultation at the request of the patient or the physician. The confinements due to the Covid-19 pandemic have upset the regulations: the MT are authorized from home since April 2019. What is the current place of teleconsultation in pharmacies compared to teleconsultation at home, at the end of the health crisis?The objective of the study to define patient preferences for medical teleconsultation.This study is based on a discrete choice experiment. The MT was modelled according to 4 attributes: (i) the physician's specialty; (ii) the reason for consultation; (iii) the waiting time to access the physician; (iv) the reimbursement by the health insurance. These attributes were declined in 11 modalities (2 for the first attribute, 3 for the others) which gives a total of 54 scenarios to be tested. For each scenario, the participant must indicate whether he prefers to teleconsult from home or from a community pharmacy. Given the number of scenarios to be tested, 9 versions of questionnaires were created, each proposing 6 scenarios. The questionnaire was distributed to people over the age of 18 physically and on social networks. A logistic regression was performed to estimate the weight of each modality within the attributes.A total of 226 responses were collected and 1338 scenarios were performed. Respondents are on average 39.1 ± 4.1 years old and 67.7% (n = 153) are women. It appears that 25.7% (n=58) of the participants have already carried out at least one medical teleconsultation. All scenarios combined, 70.8% (n = 947) of responses are in favor of medical teleconsultation from home. The specialty of the doctor does not influence the choice of the respondents. The modalities that have a positive impact in the participants’ choice in favour of a MT in a community pharmacy are: “urgent” for the attribute reason for the consultation” (OR = 1.57 [1.16; 2.13]); "shorter delay" for the attribute “waiting time” (OR = 3.24 [2.43; 4.35]) and “Without advance payment” for the attribute "Reimbursement" (OR = 1.39 [1.90; 1.02]).As it stands, it seems difficult to revitalize the MT in community pharmacies. A rapid access to care seems to be a major criterion that influence the choice of the participants. The results confirm that it seems important to rethink them about in terms of the primary care journey. As the participants return to the community pharmacies for rapid treatment, it is appropriate to highlight pharmaceutical expertise with a prescription for minor ailments, with a second-line access to MT for complex cases, as it is done the in Switzerland with the Netcare project.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="regrouplaboratory" xml:id="struct-1043157" status="VALID">
          <orgName>Université Grenoble Alpes - UFR Pharmacie</orgName>
          <orgName type="acronym">UGA UFRP</orgName>
          <date type="start">2020-01-01</date>
          <desc>
            <address>
              <addrLine>Domaine de la Merci - 38706 La Tronche cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://secteur-sante.univ-grenoble-alpes.fr/pharmacie/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-1042703" type="direct"/>
          </listRelation>
        </org>
        <org type="researchteam" xml:id="struct-1043060" status="VALID">
          <orgName>Techniques pour l'Evaluation et la Modélisation des Actions de la Santé</orgName>
          <orgName type="acronym">TIMC-ThEMAS</orgName>
          <date type="start">2021-01-01</date>
          <desc>
            <address>
              <addrLine>Domaine de la Merci, 38706 La Tronche</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.timc.fr/themas</ref>
          </desc>
          <listRelation>
            <relation active="#struct-1043049" type="direct"/>
            <relation active="#struct-301767" type="indirect"/>
            <relation name="UMR5525" active="#struct-441569" type="indirect"/>
            <relation active="#struct-1042703" type="indirect"/>
            <relation active="#struct-1043329" type="indirect"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-1042703" status="VALID">
          <idno type="IdRef">240648315</idno>
          <idno type="ROR">https://ror.org/02rx3b187</idno>
          <orgName>Université Grenoble Alpes</orgName>
          <orgName type="acronym">UGA</orgName>
          <date type="start">2020-01-01</date>
          <desc>
            <address>
              <addrLine>Adresse CS 40700 - 38058 Grenoble cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-grenoble-alpes.fr</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-1043049" status="VALID">
          <idno type="IdRef">14728936X</idno>
          <idno type="ISNI">0000 0004 4687 1979</idno>
          <idno type="RNSR">199511969L</idno>
          <idno type="ROR">https://ror.org/03985kf35</idno>
          <orgName>Translational Innovation in Medicine and Complexity / Recherche Translationnelle et Innovation en Médecine et Complexité - UMR 5525</orgName>
          <orgName type="acronym">TIMC</orgName>
          <date type="start">2021-01-01</date>
          <desc>
            <address>
              <addrLine>Domaine de la Merci, 38706 La Tronche, France</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.timc.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-301767" type="direct"/>
            <relation name="UMR5525" active="#struct-441569" type="direct"/>
            <relation active="#struct-1042703" type="direct"/>
            <relation active="#struct-1043329" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-301767" status="VALID">
          <idno type="ROR">https://ror.org/01c7wz417</idno>
          <orgName>VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement</orgName>
          <orgName type="acronym">VAS</orgName>
          <date type="start">2010-01-01</date>
          <desc>
            <address>
              <addrLine>Université de Lyon, VetAgro Sup, 69280 Marcy l'Etoile (campus vétérinaire); Université de Clermont, VetAgro Sup, 63370 Lempdes (campus agronomique)</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.vetagro-sup.fr/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-1043329" status="VALID">
          <idno type="IdRef">026388804</idno>
          <idno type="ROR">https://ror.org/05sbt2524</idno>
          <orgName>Institut polytechnique de Grenoble - Grenoble Institute of Technology</orgName>
          <orgName type="acronym">Grenoble INP</orgName>
          <date type="start">2020-01-01</date>
          <desc>
            <address>
              <addrLine>46 avenue Félix Viallet 38031 Grenoble Cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.grenoble-inp.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-1042703" type="direct"/>
          </listRelation>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>